Navigation Links
Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions

VEENENDAAL, The Netherlands, May 14 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra(R) Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy. Oncentra Brachy, the world's first fully DICOM-compatible treatment planning system, is a user-friendly Windows-based planning system that features state-of-the-art optimization algorithms to ensure efficient treatment.

Oncentra Brachy is adaptable to any clinical workflow. As well as advanced 3D contouring and margining tools, Oncentra Brachy fully supports film-based (2D) treatment planning. The system allows for planning of a wide variety of brachytherapy treatments. Oncentra Brachy is fully geared up towards Intensity Modulated Brachytherapy (IMBT).

"We have set a new benchmark in brachytherapy treatment planning," said Jos Lamers, chief executive officer of Nucletron. "We have worked with our clinical partners to develop a solution that migrates PLATO users to a new platform that fits the demands of all clinics. As part of our full range of brachytherapy solutions, Oncentra Brachy is a key element of our efforts in improving patient care."

Nucletron will display and demonstrate Oncentra Brachy throughout the 2009 GEC ESTRO in Porto, Portugal, from 13 to 16 May 2009, and at ABS 2009 in Toronto, Canada, from 31 May to 2 June 2009.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nucletron Announces 2008 Results
2. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
3. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
4. ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
5. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
6. STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL
7. Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft
8. Cancer Clinics of Excellence (CCE) Releases 62nd Evidence-Based Treatment Protocol
9. ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes
10. Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West
11. Coalition for the Advancement of Medical Research Releases New White Paper, Catalyst for Cures: Embryonic Stem Cell Research
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased ... technical presentations offered in symposia, oral sessions, workshops, awards, and posters. The ... range of applications such as, but not limited to, biotechnology, biomedical, drug discovery, ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... 24, 2015  Asia-Pacific (APAC) holds the third-largest ... market. The trend of outsourcing to low-cost locations ... higher volume share for the region in the ... margins in the CRO industry will improve. ... ( ), finds that the market earned ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):